
Publications
Scientific articles and outputs from PGNM teams and collaborators.
About
PGNM publications reflect the scientific output of the laboratory’s teams and collaborators, spanning fundamental mechanisms, disease models, technologies and translational research.
2023
Spatial Transcriptomics Reveals Signatures of Histopathological Changes in Muscular Sarcoidosis.,
Cells 2023 Nov; 12(23): .
2023
A mechano- and heat-gated two-pore domain K+ channel controls excitability in adult zebrafish skeletal muscle.,
Proc Natl Acad Sci U S A 2023 Nov; 120(45): e2305959120.
2023
A multilevel screening pipeline in zebrafish identifies therapeutic drugs for GAN.,
EMBO Mol Med 2023 Jul; 15(7): e16267.
2023
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells.,
Pathogens 2023 Apr; 12(5): .
2023
Probenecid affects muscle Ca2+ homeostasis and contraction independently from pannexin channel block.,
J Gen Physiol 2023 Apr; 155(4): .
2023
PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing.,
Nat Metab 2023 Mar; 5(3): 495-515.
2023
MBNL-dependent impaired development within the neuromuscular system in myotonic dystrophy type 1.,
Neuropathol Appl Neurobiol 2023 Feb; 49(1): e12876.
2023
Chromodomain on Y-like 2 (CDYL2) implicated in mitosis and genome stability regulation via interaction with CHAMP1 and POGZ.,
Cell Mol Life Sci 2023 Jan; 80(2): 47.
2023
Repurposing pentamidine using hyaluronic acid-based nanocarriers for skeletal muscle treatment in myotonic dystrophy.,
Nanomedicine 2023 Jan; 47(): 102623.
2023
Disrupted T-tubular network accounts for asynchronous calcium release in MTM1-deficient skeletal muscle.,
J Physiol 2023 Jan; 601(1): 99-121.